Immunization for Disease Prevention

Introduction to Immunization and Community Health

Immunization remains one of the most cost-effective public health interventions available to nursing professionals. At its core, immunization is the process whereby a person is made immune or resistant to an infectious disease, typically by the administration of a vaccine. Vaccines stimulate the body's own immune system to protect the person against subsequent infection or disease.

From a community health perspective, high vaccination coverage leads to herd immunity, sometimes called community immunity. When a large percentage of a community has become immune to an infection, the spread of disease from person to person becomes unlikely. As a result, the whole community becomes protected—not only those who have been vaccinated. This is especially critical for protecting vulnerable populations who cannot receive vaccines, such as infants too young to be immunized or individuals with compromised immune systems.

Basic Immunology: How Vaccines Work in the Body

Understanding immunology helps nurses explain vaccine benefits to skeptical clients. When a vaccine enters the body, it introduces a harmless form, piece, or weakened state of a pathogen called an antigen.

The immune system recognizes this antigen as foreign. Specialized white blood cells, including macrophages, B-lymphocytes, and T-lymphocytes, spring into action. B-lymphocytes produce specific antibodies designed to lock onto and destroy the invader.

Crucially, the immune system leaves behind memory cells. If the vaccinated individual encounters the actual disease-causing organism years later, these memory cells recognize it instantly. They mount a rapid, overwhelming defense long before the pathogen can multiply and cause severe illness.

Types of Vaccines and Their Characteristics

Vaccines are manufactured using different strategies depending on the pathogen and the immune response required. Knowing these types guides safe administration, especially for immunocompromised clients.

• Live-attenuated vaccines: Contain a weakened, live version of the pathogen. They trigger a strong, lifelong immune response with few doses, but are generally CONTRAINDICATED in pregnant women and severely immunocompromised persons (e.g., Oral Polio Vaccine, Measles vaccine).
• Inactivated vaccines: Contain killed versions of the germ. They are safer for vulnerable clients but usually require multiple doses or booster shots to maintain immunity (e.g., Inactivated Polio Vaccine).
• Subunit, recombinant, or polysaccharide vaccines: Use specific pieces of the germ, like its protein, sugar, or casing, giving a very strong and targeted immune response (e.g., Hepatitis B vaccine).
• Toxoid vaccines: Contain a toxin made by the germ that has been weakened. They teach the immune system how to fight off the toxin rather than the whole germ itself (e.g., Tetanus toxoid).

The National Immunization Schedule in Nigeria

The National Programme on Immunization (NPI) in Nigeria outlines the precise timing and sequence of vaccines recommended for infants and children. Adhering to this schedule ensures optimal protection when children are most vulnerable to infectious diseases.

• At birth: Bacille Calmette-Guérin (BCG) for tuberculosis, Oral Polio Vaccine (OPV 0), and Hepatitis B dose zero.
• 6 weeks: First doses of pentavalent vaccine (Diphtheria, Pertussis, Tetanus, Hepatitis B, Haemophilus influenzae type b), Pneumococcal Conjugate Vaccine (PCV), Rotavirus vaccine, and OPV 1.
• 10 weeks: Second doses of pentavalent, PCV, Rotavirus, and OPV 2.
• 14 weeks: Third doses of pentavalent, PCV, OPV 3, alongside Inactivated Polio Vaccine (IPV).
• 9 months: Measles vaccine first dose, Yellow Fever vaccine, and Meningitis vaccine where applicable.

Cold Chain Management and Vaccine Storage

Vaccines are biological products sensitive to heat, freezing, and light. The cold chain is a temperature-controlled supply chain that ensures vaccines maintain their potency from the manufacturing plant down to the point of administration.

Breaks in the cold chain lead to spoiled vaccines that fail to protect recipients while still causing adverse local reactions or a false sense of security. Nurses must monitor storage temperatures daily.

• Freezer storage: Vaccines like Measles, Yellow Fever, and OPV require freezing temperatures between -15°C and -25°C.
• Refrigerator storage: Vaccines like Pentavalent, PCV, IPV, and Tetanus toxoid must be stored between +2°C and +8°C. They must NEVER be frozen, as freezing destroys their adjuvants.
• Vial Monitor (VVM): A small label attached to vaccine vials that changes color when exposed to heat over time, indicating whether the vaccine remains safe to use.

Administration Techniques and Safety Protocols

Correct administration technique ensures the vaccine reaches the right tissue layer to trigger the desired immune response without causing unnecessary tissue damage or local complications.

• Intramuscular (IM): Vaccines such as Pentavalent, PCV, Hepatitis B, and Tetanus toxoid are given IM. The preferred site for infants is the anterolateral aspect of the thigh; the deltoid muscle is used for older children and adults.
• Subcutaneous (SC): Vaccines like Measles and Yellow Fever are administered subcutaneously, usually into the fatty tissue of the outer thigh or upper arm.
• Intradermal (ID): BCG is given strictly intradermal over the insertion of the deltoid muscle, forming a distinct wheal.
• Oral: OPV and Rotavirus are dropped directly into the child's mouth.

Sharps safety is paramount. Nurses must never recap needles after administration and must immediately dispose of syringes into puncture-resistant safety boxes to prevent needle-stick injuries.

Adverse Events Following Immunization (AEFI) Monitoring

An Adverse Event Following Immunization (AEFI) is any untoward medical occurrence which follows immunization and which does not necessarily have a causal relationship with the usage of the vaccine. Monitoring AEFIs maintains public trust in immunization programs.

AEFIs are classified into five major categories:

1. Vaccine product-related reaction: Caused or precipitated by a vaccine due to one or more of the inherent properties of the vaccine product.
2. Vaccine quality defect-related reaction: Caused by a defect in the vaccine product arising from the manufacturing process.
3. Immunization error-related reaction: Caused by inappropriate handling, prescribing, or administration (e.g., unsterile needle use).
4. Immunization anxiety-related reaction: Arising from anxiety about the immunization (e.g., vasovagal syncope in older children).
5. Coincidental event: Happening after vaccination but caused by something else entirely.

Nurses must educate parents on normal mild reactions, such as low-grade fever or soreness, while reporting serious or unexpected events immediately to health authorities.

Overcoming Vaccine Hesitancy and Community Mobilization

Vaccine hesitancy—the reluctance or refusal to vaccinate despite the availability of vaccination services—poses a major threat to global health. In Nigeria, rumors, cultural beliefs, and misinformation often hinder immunization uptake.

Nurses play a frontline role in addressing hesitancy through interpersonal communication and community mobilization. Effective strategies include:

• Active listening: Allowing caregivers to voice their fears and misconceptions without judgment.
• Empathetic dialogue: Providing clear, culturally sensitive, and scientifically accurate facts regarding vaccine safety and benefits.
• Community engagement: Partnering with local leaders, religious heads, and traditional rulers who hold influence in the community to advocate for routine immunization.
• Door-to-door mobilization: Utilizing community health volunteers to track defaulters and encourage clinic attendance.